Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin E Stryjewski

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Bone|July 20, 2005
Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissueIan Marriott, David L Gray, Dana M Rati, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failureEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Revista Argentina De Microbiologia|June 1, 2022
Saliva screening of health care workers for SARS-CoV-2 detectionMarcela Echavarria, Noelia S Reyes, Pamela E Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2015
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortalityMelinda K Lacy, Martin E Stryjewski, Whedy Wang, et al.
Emerging Infectious Diseases|December 21, 2020
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020Lucila M Carosella, Daniel Pryluka, Aldo Maranzana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupYohei Doi, Robert A Bonomo, David C Hooper, et al.
Scandinavian Journal of Infectious Diseases|September 22, 2010
Healthcare personnel infected with novel influenza A H1N1 virus in university hospitals in Buenos Aires, ArgentinaMarcia Querci, Martin E Stryjewski, Fabián Herrera, et al.
Journal of Clinical Microbiology|October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trialIn-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases|June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE studyMartin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
International Journal of Antimicrobial Agents|July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumoniaMartin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Bone|July 20, 2005
Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissueIan Marriott, David L Gray, Dana M Rati, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failureEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Revista Argentina De Microbiologia|June 1, 2022
Saliva screening of health care workers for SARS-CoV-2 detectionMarcela Echavarria, Noelia S Reyes, Pamela E Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2015
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortalityMelinda K Lacy, Martin E Stryjewski, Whedy Wang, et al.
Emerging Infectious Diseases|December 21, 2020
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020Lucila M Carosella, Daniel Pryluka, Aldo Maranzana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupYohei Doi, Robert A Bonomo, David C Hooper, et al.
Scandinavian Journal of Infectious Diseases|September 22, 2010
Healthcare personnel infected with novel influenza A H1N1 virus in university hospitals in Buenos Aires, ArgentinaMarcia Querci, Martin E Stryjewski, Fabián Herrera, et al.
Journal of Clinical Microbiology|October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trialIn-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases|June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE studyMartin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
International Journal of Antimicrobial Agents|July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumoniaMartin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
Pageof 9